<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101311472</journal-id>
<journal-id journal-id-type="pubmed-jr-id">34100</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Stem Cell</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Stem Cell</journal-id>
<journal-title-group>
<journal-title>Cell stem cell</journal-title>
</journal-title-group>
<issn pub-type="ppub">1934-5909</issn>
<issn pub-type="epub">1875-9777</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31130512</article-id>
<article-id pub-id-type="pmc">6944064</article-id>
<article-id pub-id-type="doi">10.1016/j.stem.2019.04.014</article-id>
<article-id pub-id-type="manuscript">NIHMS1040563</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Xu</surname>
<given-names>Ranjie</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brawner</surname>
<given-names>Andrew T.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Shenglan</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jing-Jing</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Hyosung</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xue</surname>
<given-names>Haipeng</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pang</surname>
<given-names>Zhiping P.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Woo-Yang</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hart</surname>
<given-names>Ronald P.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Ying</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Peng</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A6">6</xref>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ 08854, USA</aff>
<aff id="A2"><label>2</label>Department of Developmental Neuroscience, Munroe-Meyer Institute and Mary &amp; Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA</aff>
<aff id="A3"><label>3</label>Department of Neurosurgery and Center for Stem Cell and Regenerative Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA</aff>
<aff id="A4"><label>4</label>Department of Neuroscience and Cell Biology and Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA</aff>
<aff id="A5"><label>5</label>Department of Biological Sciences, Kent State University, Kent, OH 44242, USA</aff>
<aff id="A6"><label>6</label>Lead Contact</aff>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">AUTHOR CONTRIBUTIONS</p>
<p id="P2">R.X. and P.J. designed experiments and interpreted data. R.X. carried out most experiments, with technical assistance from A.T.B., H.K., H.X., and W.-Y.K. S.L., Y.L., and R.P.H. performed the gene expression analysis. J.-J.L. and Z.P.P. performed electrophysiological recordings. Z.P.P. and R.P.H. provided critical suggestions to the overall research direction. P.J. directed the project and wrote the manuscript together with R.X. and input from all co-authors.</p>
</fn>
<corresp id="CR1"><label>*</label>Correspondence: <email>peng.jiang@rutgers.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>06</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>1</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<issue>6</issue>
<fpage>908</fpage>
<lpage>926.e8</lpage>
<!--elocation-id from pubmed: 10.1016/j.stem.2019.04.014-->
<abstract id="ABS1">
<title>SUMMARY</title>
<p id="P3">Down syndrome (DS) is a common neurodevelopmental disorder, and cognitive defects in DS patients may arise from imbalances in excitatory and inhibitory neurotransmission. Understanding the mechanisms underlying such imbalances may provide opportunities for therapeutic intervention. Here, we show that human induced pluripotent stem cells (hiPSCs) derived from DS patients overproduce OLIG2<sup>+</sup> ventral forebrain neural progenitors. As a result, DS hiPSC-derived cerebral organoids excessively produce specific subclasses of GABAergic interneurons and cause impaired recognition memory in neuronal chimeric mice. Increased OLIG2 expression in DS cells directly upregulates interneuron lineage-determining transcription factors. shRNA-mediated knockdown of <italic>OLIG2</italic> largely reverses abnormal gene expression in early-stage DS neural progenitors, reduces interneuron production in DS organoids and chimeric mouse brains, and improves behavioral deficits in DS chimeric mice. Thus, altered OLIG2 expression may underlie neurodevelopmental abnormalities and cognitive defects in DS patients.</p>
</abstract>
<abstract abstract-type="summary" id="ABS2">
<title>In Brief</title>
<p id="P4">Using Down syndrome (DS) human iPSC brain organoid and neuronal chimeric mouse brain models, Xu et al. demonstrate that upregulated expression of OLIG2 in DS neural progenitors causes overproduction of subclass-specific GABAergic interneurons. Reducing OLIG2 expression restores interneuron differentiation and improves recognition memory in DS chimeric mice.</p>
</abstract>
<abstract abstract-type="graphical" id="ABS3">
<title>Graphical Abstract</title>
<p id="P5">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-1040563-f0008.jpg"></graphic>
</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>